Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers

Human epidermal growth factor receptor 2 (HER2) expression in breast cancer is associated with an aggressive phenotype and poor prognosis, making it an appealing therapeutic target. Trastuzumab, an HER2 antibody-based inhibitor, is currently the leading targeted treatment for HER2(+)-breast cancers....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Thiel, Kristina W., Hernandez, Luiza I., Dassie, Justin P., Thiel, William H., Liu, Xiuying, Stockdale, Katie R., Rothman, Alissa M., Hernandez, Frank J., McNamara, James O., Giangrande, Paloma H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2012
Onderwerpen:
RNA
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401474/
https://ncbi.nlm.nih.gov/pubmed/22467215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gks294
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items